Knowledge Center

Read the latest reports, white papers, and case studies about how LynxCare is transforming RWE

Knowledge center hero image

Filter

Reset all
Show Filter
Hide Filter
Show Filter
Hide Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Showing number out of number results
How technology can support the more rapid diagnosis of rare diseases
Video
This is some text inside of a div block.
The diagnostic delay for rare disease patients can go up to more than 5 years. But were you aware that technology could play a significant role in speeding up the diagnosis time of rare diseases?
re-videos re2-
Big data to gain further insights in a real-world heart failure population
Publication
This is some text inside of a div block.
A large multi-country Real-World Evidence study in heart failure shows that 1–2% of the contemporary adult population has heart failure. Through analyzing data from both national registries and Electronic Health Records, further insights into the burden of heart failure on patients and on our healthcare systems can be gained.
re-publication re2-cardiology
Detection of aTTR-CM in a real-world heart failure population by NLP-guided automated data extraction from EHRs
Publication
This is some text inside of a div block.
The underdiagnosis as well as frequently delayed diagnosis of cardiac aTTR amyloidosis (aTTR-CM), a progressive and fatal cardiomyopathy, asks for improved screening.
re-publication re2-
Facilitating RWE collaborations between hospitals and life sciences in cardiology, oncology, neurology and rare diseases
Case Study
This is some text inside of a div block.
LynxCare is facilitating RWE collaborations between a growing network of hospitals and life science companies in Europe. These federated networks enable qualitative RWE generation at scale across numerous therapeutic areas within a strict legal & ethical framework.
re-case-studies re2-
Better screening of patients for rare diseases through an NLP algorithm
Publication
This is some text inside of a div block.
A clinically-validated NLP algorithm offers a valid and accurate tool to detect red flag symptoms in medical records across multiple disciplines, supporting better screening for patients with rare diseases.
re-publication re2-neurology
LynxCare ranked in the CB Insights’ 2022 ‘Digital Health 150' list
Latest news
This is some text inside of a div block.
CB Insights has released its “Digital Health 150” 2022 list, ranking LynxCare among the 150 most promising digital health startups in the world.
re-latest-news re2-
LynxCare Appoints Alexander Rombaut as Chief Strategy Officer
Latest news
This is some text inside of a div block.
LynxCare announced it has appointed Alexander Rombaut as Chief Strategy Officer. Alexander will be leading the company’s internal operations, global strategy and execution of the company’s international expansion plans.
re-latest-news re2-
Generating the Real-World Evidence you need by making Real-World Data accessible
About LynxCare
This is some text inside of a div block.
Learn more about how LynxCare makes finding Real-World Data to generate Real-World Evidence a matter of clicks, not years.
re-about-lynxcare re2-life-sciences
Announcing LynxCare’s €20M series A Funding: the Next Step Towards More Transparency for Patients
Latest news
This is some text inside of a div block.
Today, we’re excited to announce the next big step in our journey: the completion of a €20M Series A investment round.
re-latest-news re2-
Unfortunately we have no content fit for sharing on our website yet. Reach out to our experts to find out how we are making a difference in this therapeutic area.

Curious what LynxCare can do for you?

For Life Science organizations

RWE you can trust. At scale.

Discover how
For Healthcare organizations

Put your data to work.

Discover how

”We're an active contributor to establishing the pan-European Health Data Evidence Network (EHDEN) and are eager to contribute to building the European Health Data Space to make a more inclusive European healthcare system for all patients.”

Georges De Feu
Co-founder & CEO, LynxCare